CLOs on the Move

Millendo

www.millendo.com

 
Millendo Therapeutics is focused on developing novel treatments for endocrine diseases. Our mission is to build a leading endocrine company that creates distinct and transformative treatments for a wide range of diseases where there is a significant unmet medical need. We are currently advancing two product candidates: livoletide (AZP-531) and nevanimibe (ATR-101). Livoletide is being developed for Prader-Willi syndrome while nevanimibe is in development for the treatment of two different orphan adrenal diseases: Classic Congenital Adrenal Hyperplasia (CAH) and Endogenous Cushing`s Syndrome (CS).
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.millendo.com
  • 301 N. Main Street Suite 100
    Ann Arbor, MI USA 48104
  • Phone: 734.845.9000

Executives

Name Title Contact Details
Jeffery Brinza
 Chief Administrative Officer and General Counsel Profile
Tamara Joseph
 General Counsel and Corporate Secretary Profile

Similar Companies

Aegerion

Aegerion Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases.

Aldagen

Aldagen is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

DNA Phenomics

DNA Phenomics is a Bowling Green, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Aquascience Research Group

Aquascience Research Group is a Kansas City, MO-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Alvotech

Alvotech is a fully integrated specialty biopharmaceutical company focused on development and manufacturing of high quality biosimilar medicines.